Cargando…

The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cells

Matrix metalloproteinases (MMPs) are a growing family of zinc-dependent endopeptidases that are capable of degrading various components of the extracellular matrix. These enzymes have been implicated in a variety of physiological and pathological conditions including embryogenesis and tumour invasio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rooprai, H K, Rucklidge, G J, Panou, C, Pilkington, G J
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2000
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363180/ https://www.ncbi.nlm.nih.gov/pubmed/10638966 http://dx.doi.org/10.1054/bjoc.1999.0876

Ejemplares similares

Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancer
por: Shou, Y, et al.
Publicado: (2001)

Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression
por: Hofmann, U B, et al.
Publicado: (1999)

Hepatocyte growth factor/scatter factor enhances the invasion of mesothelioma cell lines and the expression of matrix metalloproteinases
por: Harvey, P, et al.
Publicado: (2000)

Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissuenhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase
por: Collins, H M, et al.
Publicado: (2001)

Dual roles of tumour cells-derived matrix metalloproteinase 2 on brain tumour growth and invasion
por: Yu, Ching-Fang, et al.
Publicado: (2017)

Expression of vascular endothelial growth factor, matrix metalloproteinase-9 and E-cadherin in the process of lymph node metastasis in oesophageal cancer
por: Sato, F, et al.
Publicado: (1999)

Matrix metalloproteinase-1 is induced by epidermal growth factor in human bladder tumour cell lines and is detectable in urine of patients with bladder tumours.
por: Nutt, J. E., et al.
Publicado: (1998)

Stimulation of tumour growth by wound-derived growth factors
por: Abramovitch, R, et al.
Publicado: (1999)

Blood-brain barrier dysfunction significantly correlates with serum matrix metalloproteinase-7 (MMP-7) following traumatic brain injury
por: Nichols, Paul, et al.
Publicado: (2021)

Protective effect of exogenous matrix metalloproteinase-9 on chronic renal failure
por: WANG, LEI, et al.
Publicado: (2014)

The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation
por: Paju, A, et al.
Publicado: (2001)

Matrix Metalloproteinase-2 Activated by Ultraviolet-B Degrades Human Ciliary Zonules In Vitro
por: Shiroto, Yuki, et al.
Publicado: (2021)

Immunohistochemical detection of membrane-type-1-matrix metalloproteinase in colorectal carcinoma
por: Kikuchi, R, et al.
Publicado: (2000)

Matrix metalloproteinases (MMPs) in fresh human prostate tumour tissue and organ-cultured prostate tissue: Levels of collagenolytic and gelatinolytic MMPs are low, variable and different in fresh tissue versus organ-cultured tissue
por: Varani, J, et al.
Publicado: (2001)

Collagenolytic and gelatinolytic matrix metalloproteinases and their inhibitors in basal cell carcinoma of skin: comparison with normal skin
por: Varani, J, et al.
Publicado: (2000)

Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negativeatients
por: Scorilas, A, et al.
Publicado: (2001)

N -butyldeoxynojirimycin reduces growth and ganglioside content of experimental mouse brain tumours
por: Ranes, M K, et al.
Publicado: (2001)

Expression of matrix metalloproteinase-1, -2 and -3 in squamous cell carcinoma and actinic keratosis
por: Tsukifuji, R, et al.
Publicado: (1999)

Activated mesothelial cells produce heparin-binding growth factors: implications for tumour metastases
por: Jayne, D G, et al.
Publicado: (2000)

Matrix metalloproteinase-2 is downregulated in sciatic nerve by streptozotocin induced diabetes and/or treatment with minocycline: Implications for nerve regeneration
por: Ali, Sumia, et al.
Publicado: (2014)

Exogenous Tissue Inhibitor of Metalloproteinase-2 Affects Matrix Metalloproteinase-2 Expression in Conjunctival Filtering Blebs and Bleb Scarring in Rats
por: Wang, Ling, et al.
Publicado: (2018)

Matrix Metalloproteinase-2 Degrades Fibrillin-1 and Fibrillin-2 of Oxytalan Fibers in the Human Eye and Periodontal Ligaments In Vitro
por: Kawagoe, Megumi, et al.
Publicado: (2013)

The chemokine RANTES is secreted by human melanoma cells and is associated with enhanced tumour formation in nude mice
por: Mrowietz, U, et al.
Publicado: (1999)

Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic humaneratinocytes
por: Baumann, P, et al.
Publicado: (2000)

Vascular endothelial growth factor expression is independent of hypoxia in human malignant glioma spheroids and tumours
por: Parliament, M B, et al.
Publicado: (2000)

Maintenance of the Extracellular Matrix in Rat Anterior Pituitary Gland: Identification of Cells Expressing Tissue Inhibitors of Metalloproteinases
por: Azuma, Morio, et al.
Publicado: (2015)

Matrix Metalloproteinases in Cytotoxic Lymphocytes Impact on Tumour Infiltration and Immunomodulation
por: Edsparr, Karin, et al.
Publicado: (2010)

Increased Matrix Metalloproteinases in Cerebrospinal Fluids of Patients With Major Depressive Disorder and Schizophrenia
por: Omori, Wataru, et al.
Publicado: (2020)

Tumour cells engineered to secrete interleukin-15 augment anti-tumour immune responses in vivo
por: Hazama, S, et al.
Publicado: (1999)

Induction of matrix metalloproteinase-1 (MMP-1) during epidermal invasion of the stroma in human skin organ culture: keratinocyte stimulation of fibroblast MMP-1 production
por: Moon, S E, et al.
Publicado: (2001)

Circulating syndecan-1 is reduced in pregnancies with poor fetal growth and its secretion regulated by matrix metalloproteinases and the mitochondria
por: Garcha, Damanpreet, et al.
Publicado: (2021)

The Repression of Matrix Metalloproteinases and Cytokine Secretion in Glioblastoma by Targeting K+ Channel
por: Saadat, Farshid, et al.
Publicado: (2021)

Matrix metalloproteinase-8 is a regulator of the clinical aggressiveness of mammary tumours
por: Pennington, CJ, et al.
Publicado: (2008)

Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas
por: Forsyth, P A, et al.
Publicado: (1999)

Effect of oleanolic acid on the activity, secretion and gene expression of matrix metalloproteinase-3 in articular chondrocytes in vitro and the production of matrix metalloproteinase-3 in vivo
por: Kang, Dong-Geun, et al.
Publicado: (2017)

Rodent fibroblast model for studies of response of malignant cells to exogenous 5-aminolevulinic acid
por: Li, G, et al.
Publicado: (1999)

TGF-β Plays a Key Role in Morphogenesis of the Pancreatic Islets of Langerhans by Controlling the Activity of the Matrix Metalloproteinase MMP-2
por: Miralles, Francisco, et al.
Publicado: (1998)

Risk factors for testicular germ cell tumours by histological tumour type
por: Coupland, C A C, et al.
Publicado: (1999)

Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions
por: Black, M H, et al.
Publicado: (2000)

Feasibility of intraventricular administration of etoposide in patients with metastatic brain tumours
por: Fleischhack, G, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_c6rfehgif5g3femhb5oq7jec6d